The largest purchase of all time was on 2017-01-31 and amounted to 33332 shares of AnaptysBio, Inc. for $499,980.
The largest sale of all time was on 2018-04-16 and amounted to 66000 shares of AnaptysBio, Inc. for $5.73M.
No biography is available at this moment.
| 2020-10-01 | Sale | Blueprint Medicines Corporation BPMC | director | 9,815 0.0173% | $93.08 | $913,595 | +3.25% | |
| 2020-09-17 | Sale | Blueprint Medicines Corporation BPMC | director | 500 0.0009% | $80.00 | $40,000 | +23.1% | |
| 2020-07-06 | Sale | Blueprint Medicines Corporation BPMC | director | 26,007 0.0478% | $80.45 | $2.09M | +21.01% | |
| 2020-07-02 | Sale | Blueprint Medicines Corporation BPMC | director | 2,825 0.0052% | $80.13 | $226,367 | +21.27% | |
| 2020-07-01 | Sale | Blueprint Medicines Corporation BPMC | director | 2,600 0.0048% | $80.21 | $208,546 | +21.47% | |
| 2020-06-23 | Sale | Blueprint Medicines Corporation BPMC | director | 800 0.0015% | $80.00 | $64,000 | +21.59% | |
| 2020-06-22 | Sale | Blueprint Medicines Corporation BPMC | director | 26,034 0.0486% | $80.29 | $2.09M | +21.09% | |
| 2019-06-13 | Sale | Blueprint Medicines Corporation BPMC | director | 50,000 0.1017% | $90.36 | $4.52M | -18.94% | |
| 2019-06-12 | Sale | Blueprint Medicines Corporation BPMC | director | 50,000 0.1007% | $84.77 | $4.24M | -14.42% | |
| 2018-04-16 | Sale | AnaptysBio, Inc. ANAB | director | 66,000 0.2738% | $86.88 | $5.73M | -13.77% | |
| 2018-02-28 | Sale | Blueprint Medicines Corporation BPMC | director | 50,000 0.1162% | $87.89 | $4.39M | -18.41% | |
| 2017-03-14 | Sale | Blueprint Medicines Corporation BPMC | director | 140,000 0.4224% | $40.05 | $5.61M | +39.92% | |
| 2017-01-31 | AnaptysBio, Inc. ANAB | director | 33,332 0.1929% | $15.00 | $499,980 | +58.88% |